Pertussis vaccine effectiveness and duration of protection–A systematic review and meta-analysis

K Wilkinson, CH Righolt, LJ Elliott, S Fanella… - Vaccine, 2021 - Elsevier
A comprehensive review of observational pertussis vaccine effectiveness (VE) studies is
needed to update gaps from previous reviews. We conducted a systematic review of VE and …

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults

J Mertsola, O Van Der Meeren, Q He… - Clinical infectious …, 2010 - academic.oup.com
Background. Booster vaccination against tetanus and diphtheria at 10-year intervals is
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after …

M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

MA Witt, L Arias, PH Katz, ET Truong… - Clinical infectious …, 2013 - academic.oup.com
Background. Unexpected waning of immunity after pertussis vaccination is now well
described. In this study we examined whether prior vaccination with whole-cell pertussis …

Examining the benefit of vaccinating adults against pertussis

LD Olyarchuk, D Willoughby, SC Davis… - Journal of the …, 2012 - journals.lww.com
Purpose: To examine recent evidence concerning the health benefits and cost effectiveness
of replacing a single dose of adult tetanus/diphtheria vaccine with a single dose of …

Tetanus–diphtheria–acellular pertussis vaccination of adults in the USA

CA Gidengil, TJ Sandora, GM Lee - Expert review of vaccines, 2008 - Taylor & Francis
Pertussis is an important cause of morbidity and mortality, and its incidence has been
increasing in adolescents and adults over the past two decades. Waning immunity in …

Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus …

J Embree, B Law, T Voloshen… - Clinical and Vaccine …, 2015 - Am Soc Microbiol
An understanding of the antibody persistence elicited by a combined tetanus, diphtheria, 5-
component acellular pertussis, and inactivated poliovirus vaccine (Tdap-IPV) after …

Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population

HF Tseng, LS Sy, L Qian, SM Marcy… - Clinical infectious …, 2013 - academic.oup.com
Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …

Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan

M Hara, K Okada, Y Yamaguchi, S Uno… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
The recent increase of pertussis in young adults in Japan is hypothesized to be due in part
to waning protection from the acellular pertussis vaccine. While a booster immunization may …

Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …

SA Halperin, S McNeil, J Langley, M Blatter, M Dionne… - Vaccine, 2011 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …